Fairvalue-Calculator Fairvalue-Calculator
EN DE

Xinjiang Bai Hua Cun Pharma Tech Co (600721) Fair Value & Analysis

Consumer Cyclical · CN · Market cap 2.9B CNY

Price¥6.83
Fair Value¥2.28
Upside-66.6%
Quality95/100
Evidence: High Range ¥1.60 – ¥2.74

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Xinjiang Bai Hua Cun Pharma Tech Co (600721) currently trades at ¥6.83, while our model-based Fair Value estimate is ¥2.28 — implying the stock looks roughly 66.6% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers bioanalytical testing, packaging material compatibility, compound structure confirmation, quality studies, and base toxic impurity analysis. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.

Open the full interactive analysis →

Similar stocks

McDonald's Corporation (MCD) -43% Starbucks Corporation (SBUX) -74% Compass Group (CMPGF) -24% Chipotle Mexican Grill, Inc (CMGS) -48% Yum! Brands, Inc (YUM) -40% Restaurant Brands International Inc (QSR) -41%

Frequently asked questions

Is Xinjiang Bai Hua Cun Pharma Tech Co (600721) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥2.28 versus a price of ¥6.83 — about −67% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 600721?
Our 21-model fair value for Xinjiang Bai Hua Cun Pharma Tech Co is ¥2.28 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥6.83.
What is the quality score of 600721?
Xinjiang Bai Hua Cun Pharma Tech Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.